Denise Pollard-Knight

From SourceWatch
Jump to navigation Jump to search

Biographical Information

"Dr Pollard-Knight is the Managing Director for Nomura Phase4 Ventures. ... Prior to joining Nomura Dr Pollard-Knight was an investment manager in the Bioscience Unit of Rothschild Asset Management, a unit managing over US$500 million in biotech companies in the US and Europe. Dr Pollard-Knight has held R&D management positions at Amersham and Fisons plc and was a main board Director at Scientific Generics. Dr Pollard-Knight holds a PhD and BSc (Hons) from Birmingham University and was a Fulbright scholar at the University of California, Berkeley. She holds a diploma in Company Direction from the Institute of Directors. Dr Pollard-Knight is a Director of Nabriva, Cerimon, Idenix and DeveloGen."[1]

Resources and articles

Related Sourcewatch


  1. British Heart Foundation Trustees, organizational web page, accessed April 20, 2012.